NantHealth, Inc. (NHIQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0500
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
NantHealth Revenue
NantHealth had revenue of $12.47M in the quarter ending September 30, 2023, a decrease of -25.04%. This brings the company's revenue in the last twelve months to $64.27M, down -1.93% year-over-year. In the year 2022, NantHealth had annual revenue of $67.00M with 6.95% growth.
Revenue (ttm)
64.27M
Revenue Growth
-1.93%
P/S Ratio
0.03
Revenue / Employee
172.31K
Employees
373
Market Cap
1.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 67.00M | 4.35M | 6.95% |
| Dec 31, 2021 | 62.65M | -10.52M | -14.38% |
| Dec 31, 2020 | 73.17M | -4.26M | -5.50% |
| Dec 31, 2019 | 77.43M | -12.04M | -13.45% |
| Dec 31, 2018 | 89.46M | 2.79M | 3.22% |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 20.65M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Northwest Biotherapeutics | 1.38M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |